XML 20 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Unaudited Interim Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Operating Activities    
Net earnings (loss) $ 1,263 $ 1,133
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities    
Depreciation, amortization and accretion 544 318
Asset impairments 9 12
Pension and postretirement net periodic benefit cost 10 (63)
Pension and postretirement contributions (37) (34)
Deferred income taxes, net (282) 14
Gain (Loss) on Disposition of Property Plant Equipment 498 6
Stock-based compensation 36 47
Undistributed earnings in unconsolidated affiliates 20 (56)
Other, net 2 8
Operating cash provided by (used in) discontinued operations (5) (25)
Changes in operating assets and liabilities    
Trade receivables - third party and affiliates, net (16) (61)
Inventories 373 (321)
Other assets 219 26
Trade payables - third party and affiliates (171) 97
Other liabilities (398) 189
Net cash provided by (used in) operating activities 1,069 1,278
Investing Activities    
Capital expenditures on property, plant and equipment (440) (400)
Acquisitions, net of cash acquired 52 (14)
Proceeds from sale of businesses and assets, net 480 16
Other, net (58) (30)
Net cash provided by (used in) investing activities 34 (428)
Financing Activities    
Net change in short-term borrowings with maturities of 3 months or less (278) (249)
Proceeds from short-term borrowings 452 0
Repayments of short-term borrowings (603) 0
Proceeds from long-term debt 3,001 9,019
Repayments of long-term debt (3,497) (21)
Purchases of treasury stock, including related fees 0 (17)
Common stock dividends (228) (220)
Distributions to noncontrolling interests (11) (10)
Issuance cost of bridge facility 0 (63)
Other, net (52) (93)
Net cash provided by (used in) financing activities (1,216) 8,346
Exchange rate effects on cash and cash equivalents (38) (61)
Net increase (decrease) in cash and cash equivalents (151) 9,135
Cash and cash equivalents as of beginning of period 1,508 536
Cash and cash equivalents as of end of period $ 1,357 $ 9,671